Log In
Print
BCIQ
Print
Print this Print this
 

BL-7040

  Manage Alerts
Collapse Summary General Information
Company BioLineRx Ltd.
DescriptionOral synthetic oligonucleotide with dual activity on both the nervous and immune systems
Molecular Target Toll-like receptor 9 (TLR9) ; Acetylcholinesterase (AChE)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA
Latest Stage of DevelopmentPhase II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD); Treat moderately active ulcerative colitis (UC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today